healthcare News
Establishment Labs turns profitable, raises 2026 outlook
Medical technology company projects 25% revenue growth after fourth-quarter adjusted EBITDA swings to positive
Iovance surges 19% on Amtagvi revenue beat, sarcoma breakthrough
Q4 sales of $87M exceed estimates as gross margin reaches 50%, while TIL therapy shows 50% response rate in rare cancers
Harmony Biosciences rebounds on guidance despite earnings miss
Company reaffirms 2026 blockbuster revenue target of $1.04 billion for WAKIX narcolepsy treatment
Repligen beats Q4 estimates but 2026 guidance falls short
Gene therapy headwinds dampen outlook despite strong quarterly performance from bioprocessing equipment maker
Sotera Health beats estimates, extends revenue growth streak to 20 years
Sterilization services provider raises 2026 guidance on strong Sterigenics segment performance
Beam Therapeutics surges 8% on Q4 profit beat, $500M financing
Gene-editing company posts $2.33 EPS vs expected loss, extends cash runway to 2029
MoonLake shares surge 10% on Phase 2 axSpA trial success
81% of patients achieved primary endpoint in sonelokimab study, demonstrating disease modification potential
ImmunityBio surges 7% on 700% revenue growth, Saudi lung cancer approval
Biotech reports $113M full-year ANKTIVA sales and secures landmark regulatory win for lung cancer indication